Chen Wang

Chen Wang

Auto-generated profile, based on publicly available information

Chen Wang

Peking University China–Japan Friendship School of Clinical Medicine, Beijing, China

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
YDYue Deng
Yue Deng
XHXingming Huang
Xingming Huang
YHYan Hu
Yan Hu
WZWeiting Zhong
Weiting Zhong
HZHua Zhang
Hua Zhang
CWChen Wang
Chen Wang
Vascular leakage and inflammation are pathological hallmarks of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Endothelial cells (ECs) serve as a semipermeable barrier and play a key role in disease progression. It is well known that fibroblast growth factor receptor 1 (FGFR1) is required for maintaining vascular integrity. However, how endothelial FGFR1 functions in ALI/ARDS remains obscure. Here, we revealed that conditional deletion of endothelial FGFR1 aggravated LPS-induced lung injury, including inflammation and vascular leakage. Inhibition of its downstream Rho-associated coiled-coil–forming protein kinase 2 (ROCK2) by AAV Vec-tie-shROCK2 or its selective inhibitor TDI01 effectively attenuated inflammation and vascular leakage in a mouse model. In vitro, TNFα-stimulated human umbilical vein endothelial cells (HUVECs) showed decreased FGFR1 expression and increased ROCK2 activity. Furthermore, knockdown of FGFR1 activated ROCK2 and thus promoted higher adhesive properties to inflammatory cells and higher permeability in HUVECs. TDI01 effectively suppressed ROCK2 activity and rescued the endothelial dysfunction. These data demonstrated that the loss of endothelial FGFR1 signaling mediated an increase in ROCK2 activity, which led to an inflammatory response and vascular leakage in vivo and in vitro. Moreover, inhibition of ROCK2 activity by TDI01 provided great value and shed light on clinical translation.

8 April 2010 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
JLJingping Liu
Jingping Liu
LZLanlan Zhang
Lanlan Zhang
CWChen Wang
Chen Wang
HXHongyan Xu
Hongyan Xu
XZXiaojun Zhao
Xiaojun Zhao
The purpose of this study was to design and evaluate a novel target nanoparticle for disease detection and drug delivery using the biotin–avidin binding system. The formed lectin-conjugated chitosan fluorescent nanoparticles were of spherical shape (100–200 nm in diameter), which were more stable under light than pure fluorescein isothiocyanate (FITC).


4 April 2023
Verified
Other
Open access
JLJianhuang Lin
Jianhuang Lin
DGDajiang Guo
Dajiang Guo
HLHeng Liu
Heng Liu
WZWei Zhou
Wei Zhou
CWChen Wang
Chen Wang
RZRugang Zhang
Rugang Zhang
Table S3 shows the correlation between TRIM28 expression and clinical response to anti-PD1 therapy in melanoma based on a published proteomics database

4 April 2023
Verified
Other
Open access
JLJianhuang Lin
Jianhuang Lin
DGDajiang Guo
Dajiang Guo
HLHeng Liu
Heng Liu
WZWei Zhou
Wei Zhou
CWChen Wang
Chen Wang
RZRugang Zhang
Rugang Zhang
Supplementary Figures S1-S5 + Legends